Page 15 - Pfizer

US says it's ramping up research on Covid variant first found in India

The B.1.617 variant that has devastated India was first detected in the US between late February and late March.

Covid-19 vaccines are all highly protective against death, study shows

Efficacy against Covid-linked disease averaged about 85% after a full course, say University of Florida researchers.

India, Pfizer seek to bridge dispute over vaccine indemnity: Report

India has not given any manufacturer of a Covid-19 vaccine indemnity against the costs of compensation for any severe side effects, a condition Pfizer has obtained in many countries, including UK, UK

EU signs third contract with BioNTech-Pfizer for 1.8 bn vaccine doses

The European Union (EU) has signed a third contract with pharmaceutical companies BioNTech and Pfizer, securing an additional 1.8 billion Covid-19 vaccine doses between the end of 2021 and 2023

Pfizer vaccine can be stored in fridge for a month, says US regulator

Unopened, thawed vials of the vaccine can be stored in a refrigerator at 2 to 8 degrees Celsius for up to a month, up from a previous maximum limit of five days

European Union signs new deal with Pfizer-BioNTech, Hungary opts out

The EU executive arm finalised a third vaccine contract with Pfizer and BioNTech through 2023 for an additional 1.8 billion doses of their COVID-19 shot to share between the bloc's countries

How some vaccines are helping nations to exit Covid faster than others

Messenger RNA shots developed by Moderna or Pfizer and BioNTech are better at stopping people from becoming contagious, shows evidence.

Pfizer, Moderna vaccines effective against Covid variants from India: Study

The Pfizer/BioNTech and Moderna coronavirus vaccines appear to protect against Covid variants B.1.617 and B.1.618 first identified in India, researchers have reported in a new pre-print paper

Should my child get coronavirus vaccine? 7 questions answered by an expert

US FDA has expanded emergency use authorization of the Pfizer-BioNTech Covid-19 vaccine to include adolescents 12 to 15 years of age

Second Pfizer shot after 12 weeks produces more antibodies: Study

Extending 2nd dose interval increases the peak antibody response 3.5-fold

US CDC panel recommends Pfizer Covid-19 vaccine for 12-15 age group

An advisory panel of the Centres for Disease Control and Prevention on Wednesday (local time) recommended the use of Pfizer-BioNTech Covid-19 vaccine for children aged between 12 and 15

Pfizer Covid-19 vaccine now expanded to US children as young as 12

The study found no cases of Covid-19 among fully vaccinated adolescents compared to 18 among kids given dummy shots

FDA allows emergency use of Pfizer-BioNTech vax in adolescents aged 12-15

The US Food and Drug Administration (FDA)authorised the emergency use of Pfizer-BioNTech Covid-19 vaccine in adolescents aged 12-15 for the prevention of Covid-19

Sri Lanka approves Pfizer coronavirus vaccine for emergency use

Sri Lanka is the first country in South Asia to approve the Pfizer vaccine

Pfizer aims for full FDA approval of Covid vaccine for people 16 and above

Pfizer Chief Executive Albert Bourla said in a statement that the companies are aiming to win full regulatory approval in the coming months

Pfizer-BioNTech vaccine is highly effective against variants, studies find

Previous research suggested that B.1.1.7 is more infectious and more deadly than other variants, but that vaccines still worked well against it

Pfizer Covid-19 vaccine linked with fewer asymptomatic infections: Study

People who received the Pfizer Covid-19 vaccine at a US hospital had dramatically lower symptomatic and asymptomatic infections compared with their unvaccinated peers, according to a study

Pfizer-BioNTech start full US approval application for Covid-19 vaccine

If approved, the vaccine will be the first fully approved Covid-19 shot and could help ease vaccine hesitancy due to longer-term data required for an FDA approval

Covid jabs for kids in 2-11 age group: Pfizer to seek approval in Sep

Pfizer will likely seek the US Food and Drug Administration's emergency authorisation to administer its coronavirus vaccine among children between the ages of 2 and 11 in September, media reports

Pfizer lifts sales forecast for coronavirus vaccine to $26 billion

This is reflecting new contracts with governments around the world trying to halt the pandemic through rapid vaccination.